Remarkable enhancement of cinnamaldehyde antimicrobial activity encapsulated in capped mesoporous nanoparticles: A new “nanokiller” approach in the era of antimicrobial resistance

  27 March 2024

A nanodevice containing mesoporous silica nanoparticles loaded with essential oil (cinnamaldehyde) and functionalized with polypeptide ε-poly-l-lysine is developed to combat antimicrobial resistance. The device enhances cinnamaldehyde delivery through a biocontrolled uncapping mechanism triggered by proteolytic enzymes. The nanodevice improves cinnamaldehyde efficacy by 52-fold for Escherichia coli, 60-fold for S. aureus, and 7-fold for C. albicans, due to decreased volatility and increased local concentration when released.

 

Further reading: Biomaterials Advances
Author(s): Ángela Morellá-Aucejo et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed